Abstract:The human pathogenic parasite Trypanosoma brucei possess both de novo and salvage routes for the biosynthesis of pyrimidine nucleotides. Consequently, they do not require salvageable pyrimidines for growth. Thymidine kinase (TK) catalyzes the formation of dTMP and dUMP and is one of several salvage enzymes that appear redundant to the de novo pathway. Surprisingly, we show through analysis of TK conditional null and RNAi cells that TK is essential for growth and for infectivity in a mouse model, and that a catalytically active enzyme is required for its function. Unlike humans, T. brucei and all other kinetoplastids lack dCMP deaminase (DCTD), which provides an alternative route to dUMP formation. Ectopic expression of human DCTD resulted in full rescue of the RNAi growth phenotype and allowed for selection of viable TK null cells. Metabolite profiling by LC-MS/MS revealed a buildup of deoxypyrimidine nucleosides in TK depleted cells. Knockout of cytidine deaminase (CDA), which converts deoxycytidine to deoxyuridine led to thymidine/deoxyuridine auxotrophy. These unexpected results suggested that T. brucei encodes an unidentified 5'-nucleotidase that converts deoxypyrimidine nucleotides to their corresponding nucleosides, leading to their dead-end buildup in TK depleted cells at the expense of dTTP pools. Bioinformatics analysis identified several potential candidate genes that could encode 5’-nucleotidase activity including an HD-domain protein that we show catalyzes dephosphorylation of deoxyribonucleotide 5’-monophosphates. We conclude that TK is essential for synthesis of thymine nucleotides regardless of whether the nucleoside precursors originate from the de novo pathway or through salvage. Reliance on TK in the absence of DCTD may be a shared vulnerability among trypanosomatids and may provide a unique opportunity to selectively target a diverse group of pathogenic single-celled eukaryotes with a single drug.

Purine and pyrimidine metabolism in the trypanosomatidae

Fresh insights into the pyrimidine metabolism in the trypanosomatids

Purine and Pyrimidine Metabolism in Leishmania

Pyrimidine Salvage Enzymes Are Essential for De Novo Biosynthesis of Deoxypyrimidine Nucleotides in Trypanosoma Brucei

Polyamine metabolism in Leishmania: from arginine to trypanothione

Pyrimidine metabolism in Giardia lamblia trophozoites

Genetic and functional dissection of the glutamate-proline pathway reveals a shortcut for glutamate catabolism in

Lipid and fatty acid metabolism in trypanosomatids

Pyrimidine Metabolism: Dynamic and Versatile Pathways in Pathogens and Cellular Development

Polyamine Metabolism for Drug Intervention in Trypanosomatids

Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum

Human de novo purine biosynthesis

Targeting Trypanothione Metabolism in Trypanosomatids

Disorders of purine and pyrimidine metabolism

The limitations of paradigms: studies on the intermediary metabolism of Trypanosoma cruzi

Purine metabolism in plant pathogenic fungi

Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei

Surprising variety in energy metabolism within Trypanosomatidae

Energy metabolism of trypanosomatids: Adaptation to available carbon sources

Evolutionary, structural and functional insights in nuclear organisation and nucleocytoplasmic transport in trypanosomes

Meiosis and haploid gametes in the pathogen Trypanosoma brucei